Inhibitory Effects of Mitochondrial TRAP1 on Gefitinib-Resistance in Non-Small Lung Cancer Cells

被引:0
|
作者
Jeong, E. [1 ]
Hwang, K. [1 ]
机构
[1] Wonkwang Univ Hosp, Internal Med, Iksan, Jeonbuk, South Korea
关键词
TRAP1; Gefitinib resistance; Lung cancer;
D O I
10.1016/j.jtho.2017.09.1560
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P3.02-030
引用
收藏
页码:S2248 / S2248
页数:1
相关论文
共 50 条
  • [31] Overexpression of Cathepsin L is associated with gefitinib resistance in non-small cell lung cancer
    Cui, F.
    Wang, W.
    Wu, D.
    He, X.
    Wu, J.
    Wang, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (07): : 722 - 727
  • [33] Losmapimod Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer by Preventing Tetraploidization
    Yeung, Yiu To
    Yin, Shuying
    Lu, Bingbing
    Fan, Suyu
    Yang, Ran
    Bai, Ruihua
    Zhang, Chengjuan
    Bode, Ann M.
    Liu, Kangdong
    Dong, Zigang
    EBIOMEDICINE, 2018, 28 : 51 - 61
  • [34] Src mediates ERK reactivation in gefitinib resistance in non-small cell lung cancer
    Ochi, Nobuaki
    Takigawa, Nagio
    Harada, Daijiro
    Yasugi, Masayuki
    Ichihara, Eiki
    Hotta, Katsuyuki
    Tabata, Masahiro
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    EXPERIMENTAL CELL RESEARCH, 2014, 322 (01) : 168 - 177
  • [35] Overexpression of Cathepsin L is associated with gefitinib resistance in non-small cell lung cancer
    F. Cui
    W. Wang
    D. Wu
    X. He
    J. Wu
    M. Wang
    Clinical and Translational Oncology, 2016, 18 : 722 - 727
  • [36] Amphiregulin induces resistance to gefitinib in non-small cell lung cancer cell lines
    Busser, Benoit
    Lucie, Sancey
    Marie, Favrot
    Luc, Coll Jean
    Amandine, Hurbin
    BULLETIN DU CANCER, 2009, 96 : S55 - S55
  • [37] Synergistic Anticancer Effects of Curcumin and Hinokitiol on Gefitinib Resistant Non-Small Cell Lung Cancer Cells
    Lee, Tae-Bok
    Seo, Eun-Ju
    Lee, Ji-Yun
    Jun, Jin Hyun
    NATURAL PRODUCT COMMUNICATIONS, 2018, 13 (12) : 1667 - 1671
  • [39] Enhancement of sensitivity to tumor necrosis factor α in non-small cell lung cancer cells with acquired resistance to gefitinib
    Ando, K
    Ohmori, T
    Inoue, F
    Kadofuku, T
    Hosaka, T
    Ishida, H
    Shirai, T
    Okuda, K
    Hirose, T
    Horichi, N
    Nishio, K
    Saijo, N
    Adachi, M
    Kuroki, A
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 8872 - 8879
  • [40] Effects of Erlotinib in EGFR Mutated Non-Small Cell Lung Cancers with Resistance to Gefitinib
    Costa, Daniel B.
    Nguyen, Kim-Son H.
    Cho, Young C.
    Sequist, Lecia V.
    Jackman, David M.
    Riely, GregoryJ.
    Yeap, Beow Y.
    Halmos, Balazs
    Kim, Joo H.
    Jaenne, Pasi A.
    Huberman, Mark S.
    Pao, William
    Tenen, Daniel G.
    Kobayashi, Susumu
    CLINICAL CANCER RESEARCH, 2008, 14 (21) : 7060 - 7067